traffic information
|
weather
|
web feeds
| mobile
Silicon Valley
Site
Web Search by
YAHOO!
Home
News
Venture Capital
Personal Tech
The Valley
Hot Topics
Phones/Mobile
Social Networks
Green Energy
Security
Companies
Apple
Google
Facebook
Cisco Systems
Intel
Hewlett-Packard
Oracle
Yahoo
eBay
Gilead Sciences
Adobe Systems
Intuit
Netflix
Electronic Arts
Tesla Motors
Twitter
Zynga
SunPower
Solyndra
Kleiner Perkins
People
Steve Jobs
Larry Ellison
Eric Schmidt
Mark Zuckerberg
Carol Bartz
John Doerr
John Chambers
Paul Otellini
Vinod Khosla
Mark Andreessen
Ron Conway
Biz Stone
Elon Musk
Larry Page
Sergey Brin
Ann Livermore
Marissa Mayer
Sheryl Sandberg
T.J. Rodgers
Mark Hurd
columnists
gmsv
Special Reports
Venture Capital Survey
Salary Survey
Silicon Valley 150
Services
RSS Feeds
Mobile Edition
Widgets
Contact Us
Jobs
Advertising
Archives
Go to MercuryNews.com
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Pfizer, Inc.
(NY:
PFE
)
28.62
USD
-0.08 (-0.28%)
Streaming Delayed Price
/ Updated:
10:04 AM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
5,749,748
Open
28.71
Bid (Size)
28.62 (18300)
Ask (Size)
28.63 (4000)
Prev. Close
28.70
Today's Range
28.56 - 28.73
52wk Range
21.40 - 31.15
Shares Outstanding
7,093,223,330
Dividend Yield
3.14%
Top News
More News
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive...
Read More
category
companyNews
from
Reuters: Company News
Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8355790 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
May 20, 2013
from
Business Wire News Releases
6 Healthy Products That Aren't
May 20, 2013
category
SKX
,
JNJ
,
WMT
, and 2 more.
from
Minyanville Headlines
March 2014 Options Now Available For Pfizer Inc (PFE)
May 20, 2013
category
Stocks
from
Market News Video
Noteworthy ETF Inflows: VTV, GE, PFE, T
May 20, 2013
category
ETFs
from
ETF Channel
More Details about Hisun-Pfizer and Merck-Simcere JVs
May 20, 2013
from
ChinaBio® Today
Medtronic Q4 Earnings: Modest Revenue Growth And Gross Margin Pressure Expected
May 20, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Reveal Insider Trading for Ford Motor, Autodesk, Pfizer, Oracle, Exxon Mobil, and Home Depot
May 20, 2013
from
PR Newswire
Pfizer Earnings Review: 20 Days after Announcement Shares Down 0.4% (PFE)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
web feeds
